Informace o publikaci
Regulation of veterinary point-of-care testing in the European Union, the United States of America and Japan
| Autoři | |
|---|---|
| Rok publikování | 2020 |
| Druh | Článek v odborném periodiku |
| Časopis / Zdroj | REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES |
| Fakulta / Pracoviště MU | |
| Citace | |
| www | https://doc.oie.int/dyn/portal/index.xhtml?page=alo&aloId=42232 |
| Doi | http://dx.doi.org/10.20506/rst.39.3.3171 |
| Klíčová slova | European Union; Japan; Point-of-care testing; Regulation; United States of America; Veterinary diagnostics |
| Popis | Point-of-care testing (POCT) is used to detect diseases and other conditions or to monitor therapeutic procedures. In veterinary medicine, POCT not only helps during the prevention, diagnosis and treatment of animal diseases but it also has a direct impact on human health by safeguarding food supplies and preventing zoonoses. Despite its importance, the regulation of the quality, safety and effectiveness of POCT products is rarely discussed. This review reveals that the level of regulatory surveillance of veterinary POCT products in the European Union (EU), the United States of America and Japan is strikingly different, ranging from no regulation (EU) to comprehensive regulation, which is comparable to the procedures for the regulation of human in vitro medical devices (Japan). Details about the licensing procedures in these three locations, discussion of their strengths and weaknesses, and suggestions for possible future development of the regulation of these products are also provided. |